Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
60%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting240%
completed360%

Recent Activity

2 active trials
Showing 5 of 5
recruitingnot_applicable

APIXABAN App Study

NCT06903845
completednot_applicable

Video-call Assisted Assessment of Acute Stroke in Addition to Stroke Severity Scales in a Prehospital Setting

NCT05737420
recruiting

Enhancing Prehospital Stroke Diagnosis

NCT06427746
completed

Telemedicine for SNAS Patients in COVID-19 Pandemic

NCT04894331
completednot_applicable

Patient Satisfaction With Postoperative Communication Modality

NCT04338425

Clinical Trials (5)

Showing 5 of 5 trials
NCT06903845Not Applicable

APIXABAN App Study

Recruiting
NCT05737420Not Applicable

Video-call Assisted Assessment of Acute Stroke in Addition to Stroke Severity Scales in a Prehospital Setting

Completed
NCT06427746

Enhancing Prehospital Stroke Diagnosis

Recruiting
NCT04894331

Telemedicine for SNAS Patients in COVID-19 Pandemic

Completed
NCT04338425Not Applicable

Patient Satisfaction With Postoperative Communication Modality

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5